Price $53.04 |
Market Cap
5.41B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
28.5
|
P/B
2.22
|
P/S
2.73
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
5.30%
|
|
ROA
-
|
EPS Growth
-
|
Current Ratio
1.9
|
Debt/Equity
156.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Viatris Inc (VTRS) | $14.53 | - | 3.30% | 16.39B | Strong Buy |
| Biomerica, Inc. (BMRA) | $4.37 | - | - | 48.8M | Strong Buy |
| Endo International PLC (ENDP) | $3.21 | - | - | 923M | Strong Buy |
| Puma Biotechnology Inc (PBYI) | $2.40 | - | - | 130M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.54 | - | 3.50% | 138.77B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
